The Biotechnology industry today
How the Biotechnology industry stands against its own history and against the 500 largest US companies. We do not say where it goes next.
Close of Friday 6 November 2026 · updated every trading day
206 US companies of $300 million or more · $1.01T in total
ValuationWe compare today's value with every month since 2006. The usual range holds the middle 40% of those months. The marks show the value 1 month, 1 year and 5 years ago.
Prices against profits, sales and dividends
Price to earnings (P/E)What this measures: the total market value of the companies divided by their total profit of the last 12 months. Companies that lose money count too.
How high are prices against profits?
Not enough history yet
Show details
Last 10 yearsEach point is one month. The dot is today.
Price to sales (P/S)What this measures: the total market value of the companies divided by their total sales of the last 12 months.
How high are prices against sales?
Lower than usual
Low · lower than in 7 of 10 months since 2006
Show details
Last 10 yearsEach point is one month. The dot is today.
Dividend yieldWhat this measures: the dividends of the last 12 months divided by the total market value, in percent. A low yield goes with high prices.
How much do the companies pay in dividends for their price?
In the usual range
Normal · higher than in 6 of 10 months since 2006
Show details
Last 10 yearsEach point is one month. The dot is today.
Returns
How did the industry do against the 500 largest US companies?
| Period | This industry | 500 largest | Difference |
|---|---|---|---|
| 1 month | +0.8% | −1.4% | 2.3 pts more |
| 1 year | +52.0% | +9.9% | 42.1 pts more |
| 5 years | +29.0% | +65.7% | 36.7 pts less |
Total returns with dividends, weighted by market value, to the close of October 2026. Past results do not show future results.
Largest companies
The three largest companies
- 01Vertex Pharmaceuticals IncorporatedVRTX13.8% of the industry
- 02Moderna, Inc.MRNA10.0% of the industry
- 03Regeneron Pharmaceuticals, Inc.REGN9.3% of the industry
Show all 10
- 04Revolution Medicines, Inc.RVMD4.1% of the industry
- 05Insmed IncorporatedINSM2.5% of the industry
- 06Incyte CorporationINCY2.4% of the industry
- 07United Therapeutics CorporationUTHR2.4% of the industry
- 08Alnylam Pharmaceuticals, Inc.ALNY2.1% of the industry
- 09Exelixis, Inc.EXEL1.7% of the industry
- 10Neurocrine Biosciences, Inc.NBIX1.7% of the industry
Map
Its companies among the 500 largest
The map shows the industry's companies among the 500 largest US companies: 10 of its 206 companies.
The typical companyThe median of the industry's US companies. We show a figure only when 5 or more companies have it.
The typical company in this industry
- Operating margin87 companies−1433.0%
- Sales growth over 1 year85 companies653.0%
- Return on invested capital55 companies−1239.0%